StockData
BioCardia, Inc. logo

BioCardia, Inc. (BCDA) stock

BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.77−0.02 (-2.06%)

Close on Nov 18, 2026Market cap $11.69MP/E –Yield –

BioCardia operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

BioCardia's operating income for the twelve months ending Jun 30, 2026 was -$7.39M. For fiscal 2025 it was -$8.28M. The highest annual figure on record is $231.00K in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.28M–
FY2024Dec 31, 2024-$8.00M–
FY2023Dec 31, 2023-$11.64M–
FY2022Dec 31, 2022-$11.90M–
FY2021Dec 31, 2021-$12.63M–
FY2020Dec 31, 2020-$15.53M–
FY2019Dec 31, 2019-$14.21M–
FY2018Dec 31, 2018-$14.10M–
FY2017Dec 31, 2017-$12.41M–
FY2016Dec 31, 2016-$7.61M–
FY2015Dec 31, 2015-$5.41M-2441.6%
FY2014Dec 31, 2014$231.00K+2466.7%
FY2013Dec 31, 2013$9.00K–
FY2012Dec 31, 2012-$339.00K–
FY2011Dec 31, 2011-$618.00K–
FY2010Dec 31, 2010-$583.00K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.62M–
Q1 FY2026Mar 31, 2026-$2.27M–
Q4 FY2025Dec 31, 2025-$2.01M–
Q3 FY2025Sep 30, 2025-$1.49M–
Q2 FY2025Jun 30, 2025-$2.05M–
Q1 FY2025Mar 31, 2025-$2.73M–
Q4 FY2024Dec 31, 2024-$2.32M–
Q3 FY2024Sep 30, 2024-$1.76M–
Q2 FY2024Jun 30, 2024-$1.65M–
Q1 FY2024Mar 31, 2024-$2.28M–
Q4 FY2023Dec 31, 2023-$2.08M–
Q3 FY2023Sep 30, 2023-$2.60M–
Q2 FY2023Jun 30, 2023-$3.45M–
Q1 FY2023Mar 31, 2023-$3.51M–
Q4 FY2022Dec 31, 2022-$3.02M–
Q3 FY2022Sep 30, 2022-$3.06M–
Q2 FY2022Jun 30, 2022-$2.50M–
Q1 FY2022Mar 31, 2022-$3.33M–
Q4 FY2021Dec 31, 2021-$3.46M–
Q3 FY2021Sep 30, 2021-$2.71M–
Q2 FY2021Jun 30, 2021-$3.49M–
Q1 FY2021Mar 31, 2021-$2.97M–
Q4 FY2020Dec 31, 2020-$3.50M–
Q3 FY2020Sep 30, 2020-$3.85M–
Q2 FY2020Jun 30, 2020-$3.57M–
Q1 FY2020Mar 31, 2020-$4.61M–
Q4 FY2019Dec 31, 2019-$3.54M–
Q3 FY2019Sep 30, 2019-$3.23M–
Q2 FY2019Jun 30, 2019-$3.76M–
Q1 FY2019Mar 31, 2019-$3.69M–
Q4 FY2018Dec 31, 2018-$3.66M–
Q3 FY2018Sep 30, 2018-$3.57M–
Q2 FY2018Jun 30, 2018-$3.25M–
Q1 FY2018Mar 31, 2018-$3.62M–
Q4 FY2017Dec 31, 2017-$3.52M–
Q3 FY2017Sep 30, 2017-$3.04M–
Q2 FY2017Jun 30, 2017-$2.97M–
Q1 FY2017Mar 31, 2017-$2.88M–
Q4 FY2016Dec 31, 2016-$3.47M–
Q3 FY2016Sep 30, 2016-$1.68M–

More BioCardia figures

See a number that looks wrong?